We are live on ! Find out more
JAMONY

Jacob Asset Management of New York Portfolio holdings

AUM $70.9M
1-Year Est. Return 14.28%
This Fund
S&P 500
This Quarter Est. Return
+4.12%
1 Year Est. Return
+14.28%
3 Year Est. Return
+22.72%
5 Year Est. Return
10 Year Est. Return
AUM
$82.2M
AUM Growth
-$9.92M
Cap. Flow
-$6.16M
Cap. Flow %
-7.5%
Top 10 Hldgs %
41.55%
Holding
72
New
5
Increased
18
Reduced
42
Closed
5

Sector Composition

Rank Sector Weight
1 Technology 43.97%
2 Healthcare 25.08%
3 Consumer Discretionary 9.79%
4 Communication Services 8.66%
5 Industrials 4.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVT
26
DELISTED
Cvent Holding Corp. Common Stock
CVT
$1.25M 1.52%
230,797
-282,013
-55% -$1.56M
CELC icon
27
Celcuity
CELC
$4.49B
$1.03M 1.25%
73,209
-24,840
-25% -$254K
HUYA
28
Huya Inc
HUYA
$547M
$924K 1.12%
+233,865
New +$592K
MOMO
29
Hello Group
MOMO
$867M
$919K 1.12%
+102,320
New +$607K
TRAK icon
30
ReposiTrak
TRAK
$152M
$898K 1.09%
181,512
-21,050
-10% -$107K
IDYA icon
31
IDEAYA Biosciences
IDYA
$3.56B
$863K 1.05%
47,512
-26,757
-36% -$450K
JOYY
32
JOYY Inc
JOYY
$3.74B
$849K 1.03%
+26,860
New +$777K
BABA icon
33
Alibaba
BABA
$300B
$846K 1.03%
9,607
+1,312
+16% +$103K
CDXS icon
34
Codexis
CDXS
$175M
$782K 0.95%
167,901
-20,612
-11% -$113K
BMTX
35
DELISTED
BM Technologies, Inc.
BMTX
$755K 0.92%
145,000
NXDR
36
Nextdoor Holdings
NXDR
$986M
$731K 0.89%
354,802
-1,616
-0.5% -$3.78K
PI icon
37
Impinj
PI
$5.49B
$695K 0.85%
6,369
-17,557
-73% -$1.85M
HRTX icon
38
Heron Therapeutics
HRTX
$64.7M
$668K 0.81%
267,028
+27,682
+12% +$89.2K
EDU icon
39
New Oriental
EDU
$8.49B
$663K 0.81%
+19,050
New +$538K
MAPS
40
DELISTED
WM TECHNOLOGY INC A
MAPS
$640K 0.78%
633,843
-15,146
-2% -$21.9K
XPL icon
41
Solitario Resources
XPL
$73.6M
$629K 0.77%
1,014,300
-20,700
-2% -$11.7K
WRN
42
Western Copper and Gold
WRN
$543M
$605K 0.74%
339,950
-37,550
-10% -$57.4K
KRYS icon
43
Krystal Biotech
KRYS
$9.85B
$550K 0.67%
6,937
+3,175
+84% +$236K
USIO icon
44
Usio Inc
USIO
$65.7M
$531K 0.65%
332,100
-37,400
-10% -$74.9K
ATOM icon
45
Atomera
ATOM
$216M
$463K 0.56%
74,400
-600
-0.8% -$4.92K
ABUS icon
46
Arbutus Biopharma
ABUS
$908M
$437K 0.53%
187,400
-32,600
-15% -$78K
DTIL icon
47
Precision BioSciences
DTIL
$205M
$387K 0.47%
10,847
+937
+9% +$37K
CTSO icon
48
Cytosorbents Corp
CTSO
$23.3M
$384K 0.47%
247,940
-5,060
-2% -$7.51K
DMAC icon
49
DiaMedica Therapeutics
DMAC
$369M
$369K 0.45%
233,730
-4,770
-2% -$6.42K
AMRS
50
DELISTED
Amyris Inc.
AMRS
$262K 0.32%
171,100
+17,476
+11% +$39K

Similar funds

Jacob Asset Management of New York's Q4 2022 Portfolio in Review

As of Q4 2022, Jacob Asset Management of New York held 72 positions worth $82.2M, down 11% from $92.1M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Jacob Asset Management of New York withdrew a net $6.16M in Q4 2022, closing 5 positions and reducing 42 holdings. Its most notable exit was Poshmark, Inc. Class A Common Stock, an estimated $1.59M position sold in full.

By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 43% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Jacob Asset Management of New York opened a new position in JOYY Inc worth $849K.

  • Jacob Asset Management of New York's largest Q4 2022 buy was JOYY Inc: 26,860 shares worth $849K.
  • Jacob Asset Management of New York added most to Silvergate Capital Corporation in Q4 2022, an estimated $1.36M increase.
  • Jacob Asset Management of New York's biggest Q4 2022 reduction was Impinj, cutting an estimated $1.85M.
  • Jacob Asset Management of New York fully exited Poshmark, Inc. Class A Common Stock in Q4 2022, selling an estimated $1.59M.
  • Jacob Asset Management of New York's ten largest holdings make up 42% of its $82.2M portfolio in Q4 2022.
  • Jacob Asset Management of New York opened 5 new positions and closed 5 in Q4 2022.
  • Jacob Asset Management of New York's portfolio value fell 11% quarter-over-quarter to $82.2M.

Based on Jacob Asset Management of New York's 13F filing for Q4 2022, filed 14 Feb 2023.